Frovatriptan Succinate Tablet, Film Coated
Product Images NDC 69315-157

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Frovatriptan Succinate (NDC 69315-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

Cartonlabel (Cartonlabel)
This text contains information related to the medication and its packaging. It mentions keeping the medication away from children, provides a product code of "8 gL-sSL-5156" and includes details about Frovatriptan Succinate Tablets in a unit-dose package of 9 tablets. It also references a package insert for prescribing information. The text is a mix of internal codes, dosage instructions, and pharmaceutical terminology.*
FDA Label Image

Chemstruct (Chemstruct)

FDA Label Image

Figure01 (Figure01)

Figure01 (Figure01)
This is a table displaying the estimated probability of response to different treatments over time. The treatments being compared are placebo and Frovatriptan 2.5 mg. The response rates are listed at 10% intervals from 100% down to 10%. The time from the initial dose in hours is also provided for reference.*
FDA Label Image

Figure02 (Figure02)

Figure02 (Figure02)
This text provides an estimated probability chart for remedication or rescue over a period of 24 hours, with time indicated on the x-axis and probabilities ranging from 0% to 100% on the y-axis. The chart shows a decreasing trend in the probability of remedication or rescue as time progresses from the initial dose.*
FDA Label Image

Foildlabel (Foillabel)

Foildlabel (Foillabel)
This is a product description for Frovatriptan Succinate Tablets distributed by Leading Pharma LLC. The tablets are 25 mg each and are intended for treatment as indicated on the packaging. The tablets come in packs indicated by the NDC code: 69315-157-13. The distributor is based in Fairfield, NJ, USA. The tablets are prescription-only medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.